Nephrology Doctors in Midland, TX Accepting Medicare

2 Nephrology doctors found. Showing 1 - 2

Joy Okwuwa, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3302 W Golf Course Rd Ste 100, Midland, TX 79703 Phone: 432-522-2304    Fax: 432-522-2307

Mamoun E Bashir, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3302 W Golf Course Rd Ste 100, Midland, TX 79703 Phone: 432-522-2304    Fax: 432-522-2307

News Archive

Researchers describe an underlying biological basis for mylagic encephalomyelitis/chronic fatigue syndrome

Mylagic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling and complex illness. Affected persons often cannot pursue ordinary activities - physical or mental - because of an incapacitating loss of energy and other symptoms, and may find themselves confined to bed or house-bound for years.

Study: Subtle hearing deficits can change the brains of young people

Cranking up your headphones or scrambling for a front-row spot at rock shows could be damaging more than your hearing.

Tranexamic acid: an interview with Prof Ian Roberts

Tranexamic acid is a medicine that reduces blood clot breakdown. In this way it helps in patients with bleeding.

Study examines effects of pay-for-performance-reimbursing health care in China's Ningxia Province

Pay-for-performance-reimbursing health care providers based on the results they achieved with their patients as a way to improve quality and efficiency-has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact.

FDA accepts Sol-Gel's Investigational New Drug Application for DER45-EV Gel

Sol-Gel Technologies announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to initiate Phase II studies with DER45-EV Gel in rosacea patients.

Read more Medical News

› Verified 2 days ago